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Abstract Objective: The objective of our study was to determine the frequency and predisposing
factors of pharyngocutaneous ﬁstula in postlaryngectomy patients.
Materials and methods: Charts of those patients who were treated with total laryngectomy for
laryngeal carcinoma in our department from 2000 to 2008 were reviewed. Total 77 patients were
included in the study. The variables studied for the development of pharyngocutaneous ﬁstula
(PCF) after total laryngectomy were: age and gender, diabetes mellitus, post-operative hemoglobin,
ischemic heart disease, chronic obstructive pulmonary disease, tumor characteristics including
tumor site, stage, differentiation and extension into pyriform sinus, pre-operative radiotherapy,
pre-operative chemotherapy, pre-operative tracheostomy and positive surgical margins.
Results: Univariate analysis showed diabetes, pre-operative radiotherapy, pre-operative chemo-
therapy and pre-operative tracheostomy to be signiﬁcantly associated with the formation of PCF.
However, multivariate regression revealed that the only pre-operative radiotherapy was highly asso-
ciated with the formation of PCF (OR= 132.923, P= 0.001).
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Conclusions: We found 28.6% incidence of pharyngocutaneous ﬁstula mainly because of the
number of patients undergoing radiotherapy and chemotherapy as primary treatment for laryngeal
cancers is increasing with current approach of organ preservation protocol.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Ear, Nose, Throat and
Allied Sciences.
1. Introduction
Head and neck cancer is the ninth common cause of death in
the United States according to the national statistics.1 In Paki-
stan head and neck cancer is ranked among the most common
malignancies in male2,3 and the carcinoma of larynx is the 2nd
most common. The treatment of advanced laryngeal cancer
had traditionally been total laryngectomy (TL) followed by
adjuvant radiotherapy. For past few decades, focus of primary
treatment for advanced laryngeal cancers has shifted from sur-
gery to radiotherapy and chemotherapy with the intention of
organ preservation protocol.4
A large number of people still undergo total TL as either
primary treatment for advance laryngeal cancers i.e. stage III
and stage IV,4 or as a management of recurrent/persistent dis-
ease after chemo radiation or treatment related tissue damage
(like chondroradionecrosis).5 TL for laryngeal cancers is asso-
ciated with a high rate of complications such as pharyngocuta-
neous ﬁstula (PCF), chyle leak, wound infection, hemorrhage,
pneumonia and embolism; among these complications pharyn-
gocutaneous ﬁstula is believed to be the most common.5 Devel-
opment of PCF is not only associated with increased hospital
stay, patient discomfort, high health costs and delayed adju-
vant treatment but can also lead to life-threatening outcomes
such as carotid artery rupture.6,7 Studies have revealed inci-
dence of PCF to be as high as 65%.8
The etiology of PCF remains unclear, however, it is be-
lieved to be multi-factorial in origin.9 Various factors have
been implicated in the formation of PCF including diabetes
mellitus, pre-operative hypoalbuminemia, post-operative
hemoglobin less than 12.5 g/dl, liver disease, pre-operative
radiotherapy, tumor size, residual tumor, positive surgical
margins,10,11 location of tumor, cervical lymph node metasta-
sis, concurrent neck dissection, intra-operative blood transfu-
sion, extent of surgery, operative time, surgical technique
and gastro-esophageal reﬂux disease.12
It is evident that the same factors have not been found sig-
niﬁcant in all studies; hence the controversy still remains in
identifying high-risk patients. With many different etiological
agents responsible for the disease and a different level of care
compared to western countries, in Pakistani population Udai-
purwala and colleagues13 quoted the incidence of PCF 8.9%.
However they did not investigate the role of above mentioned
factors in formation of PCF. Our study was aimed to identify
the rate of PCF after total laryngectomy and the associated
signiﬁcant risk factors among these patients of the developing
world particularly through multivariate analysis.
2. Materials and methods
The charts were reviewed of those patients who were treated
with total laryngectomy for laryngeal carcinoma in our depart-
ment from 2000 to 2008. Total 90 patients underwent TL, of
these 77 patients were included in the study. Thirteen patients
were excluded due to inadequate data or ﬂap reconstruction to
achieve primary closure. The variables included age and gen-
der, diabetes mellitus (DM), post-operative hemoglobin, ische-
mic heart diseases (IHD) and chronic obstructive pulmonary
disease (COPD) and tumor characteristics including tumor
site, stage, differentiation and extension into pyriform sinus,
pre-operative radiotherapy and pre-operative chemotherapy
and surgical details (preoperative tracheotomy and positive
surgical margins). The data were analyzed using SPSS 18.
Using Chi-square test and odds ratio, univariate analysis was
carried out. Variables that were found statistically signiﬁcant
on univariate analysis were reanalyzed using multivariate
regression.
3. Results
There were 70 males (91%) and seven females (9%). The mean
age was 57 years. Further characteristics of our patients are gi-
ven in Table 1. Of 77 patients 22 (28.6%) developed pharyngo-
cutaneous ﬁstula. The mean time taken for PCF formation was
7 days (range = 3–14 days) see Table 2. Univariate analysis
was made by calculating odds ratio (OR) and using the Chi-
square test to calculate level of signiﬁcance. This showed dia-
betes, pre-operative radiotherapy, pre-operative chemotherapy
and pre-operative tracheostomy to be signiﬁcantly associated
with the formation of PCF (Table 3). However, multivariate
regression (Table 4) revealed only the pre-operative radiother-
apy highly associated with the formation of PCF (OR=
132.923, P= 0.001).
4. Discussion
Complications following total laryngectomy (TL) can be di-
vided into local (infection, hemorrhage, ﬁstula or chyle leak)
and general (myocardial infarction, urinary tract infection,
pulmonary, renal or metabolic)14 Of all the complications of
laryngectomy the occurrence of PCF is believed to be the most
common.15
Our study revealed a high rate of PCF of 28.6% among pa-
tients undergoing TL. Although this rate was in agreement
with a number of studies,16,17 it is still very high compared
to data from recent studies in developed countries, which
quoted incidences between 12% and 16%.18,19 Numerous fac-
tors have been implicated to be involved in the formation of
PCF. Using univariate analysis, our study showed that pre-
operative radiotherapy, diabetes, pre-operative tracheostomy,
post-operative hemoglobin less than 12 g/dl and pre-operative
chemotherapy to be associated with ﬁstula formation, whereas
only pre-operative radiotherapy was found to be statistically
signiﬁcant on multivariate analysis.
With increased reliance on organ preservation protocols,
an increased number of patients receive chemotherapy and
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radiotherapy as treatment for laryngeal cancers. Though this
has offered good loco-regional disease control,20 the associa-
tion of previous radiotherapy with the formation of PCF has
been well established.21 In our study, there were 17 patients
who had received prior external beam radiotherapy. Fifteen
(88.2%) of 17 developed PCF compared to only 11.7% of
non-irradiated patients. Radiation is known to be toxic to nor-
mal tissues and impair surgical wound healing which is signif-
icantly manifested microscopically by obliterative endarteritis
and ﬁbrosis.22
McCombe et al.23 and Chang et al.24showed that PCF
occurring in previously irradiated patients tends to last longer
and required surgical correction more often compared to PCF
occurring in non-irradiated patients. In our study three pa-
tients (13.6%) underwent surgical reconstruction; they all were
those who received radiotherapy before the surgery. The asso-
ciation between co-morbidities like diabetes mellitus, postoper-
ative anemia, ischemic heart disease and chronic obstructive
pulmonary disease with the formation of PCF has been studied
at several occasions.25 Our study also showed that diabetes
and post-operative anemia (hemoglobin of less than 12 g/dl)
were statistically associated with the development of PCF in
univariate analysis but the preoperative radiotherapy is the
only variable that was found signiﬁcant on multivariate analy-
sis. The association between diabetes and PCF is not surpris-
ing keeping in mind that surgery and anesthesia impair
glucose control by aggravating insulin resistance, with the
resultant hyperglycemia causing impaired wound healing and
leukocyte function leading to increased susceptibility to infec-
tions.26 Our study did not verify the association of PCF with
ischemic heart disease, diabetes mellitus and chronic obstruc-
tive pulmonary disease; however a few studies have shown a
statistically signiﬁcant relationship.10,26
The role of other oncological factors such as tumor site, tu-
mor stage, tumor differentiation, extension of surgery to pyri-
form sinus and positive surgical margins did not appear to play
Table 4 Multivariate analysis.
VARIABLES Odds ratio P value
Diabetes mellitus 5.125 0.081
Stage 0.121 0.070
Preoperative radiotherapy 132.923 0.001
Hemoglobin < 12 g/dl 2.165 0.487
Preoperative tracheostomy 1.475 0.656
Pre-operative chemotherapy 0.108 0.231
Table 2 Time taken for ﬁstula formation.
Early 3 days
Late 14 days
Mean 7 days
Table 3 Univariate analysis.
Variable Odds ratio P value
Gender 2.571 0.395
Site 1.334 0.400
Diabetes 4.747 0.009
IHD 0.928 0.918
COPD 1.815 0.396
Pyriform sinus involvement 1.029 0.928
Stage 0.287 0.043
Tumor diﬀerentiation 1.828 0.333
Pre-operative radiotherapy 56.786 0.002
Pre-operative chemotherapy 5.889 0.050
Hemoglobin < 12 g/dl 3.750 0.099
Pre-operative tracheostomy 2.986 0.042
Positive margins 4.443 0.999
Table 1 Patients’ characteristics.
Age Mean 56.82
Range 23-80 years
Gender Male 70 (90.9%)
Female 07 (09.1%)
Tumor Grade Well diﬀerentiated 09 (11.7%)
Moderately diﬀerentiated 64 (83.1%)
Poorly diﬀerentiated 04 (05.2%)
Tumor stage Stage III 28 (36.4%)
Stage IV 49 (63.6%)
Received Preoperative Radiotherapy Yes 17 (22.1%)
No 60 (77.9%)
Received Preoperative chemotherapy Yes 6 (7.8%)
No 71 (92.2%)
Tumor margins Positive 2 (2.6%)
Negative 75 (97.4%)
Prior tracheotomy Yes 22 (28.6%)
No 55 (71.4%)
Post-operative Hemoglobin More than 12 g/dl 17(22.1%)
Less than 12 g/dl 60 (77.9)
Diabetes Yes 16 (20.8%)
No 61 (79.2%)
IHD Yes 11(14.3%)
No 66 (85.7%)
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a role in the formation of PCF in our study, as previously re-
ported. However just like other factors, literature search re-
vealed controversial results with some reports showing an
association between PCF and tumor site, tumor stage, exten-
sion of surgery to the pharynx, and positive surgical margins.
Possible negative effect of tumor cells on healing and wider
resection leaving inadequate tissue for closure are reasons that
have been hypothesized to be involved in the formation of
PCF in the presence of positive surgical margins and higher tu-
mor stage respectively.
The management of PCF includes conservative approach
and surgical reconstruction. Conservative management in-
volves daily dressings, nasogastric tube for feeding till ﬁstula
heals and antibiotics if required with the success rate of about
86%. Surgical option is needed where conservative manage-
ment failed. This includes primary closure of the wound or ﬂap
reconstruction e.g. pectoralis major or free forearm ﬂaps.
In our patients most of the ﬁstulas were successfully man-
aged conservatively with daily dressings and only three pa-
tients required surgical reconstruction (two with pectoralis
major ﬂap and one with deltopectoral ﬂap).
5. Conclusion
The incidence of PCF is still high and remains a cause of pa-
tient morbidity as well as increased hospitalization and health
costs. We found 28.6% incidence of pharyngocutaneous ﬁstula
owing to the number of patients undergoing radiotherapy and
chemotherapy as primary treatment for laryngeal cancers is
increasing with current approach of organ preservation
protocol.
References
(1). Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer
statistics 2009. CA Cancer J Clin. 2009;59(4):225–249.
(2). Bhurgri Y, Bhurgri A, Usman A, et al. Epidemiological review of
head and neck cancers in Karachi. Asian Pac J Cancer Prev.
2006;7(2):195.
(3). Hanif M, Zaidi P, Kamal S, Hameed A. Institution-based cancer
incidence in a local population in Pakistan: nine year data
analysis. Asian Pac J Cancer Prev. 2009;10(2):227–230.
(4). Kada S, Hirano S, Tateya I, et al. Ten years single institutional
experience of treatment for advanced laryngeal cancer in Kyoto
University. Acta Otolaryngol. 2010;130(S563):68–73.
(5). Herranz J, Sarandeses A, Ferna´ndez MF, Barro CV, Vidal JM,
Gavila´n J. Complications after total laryngectomy in nonradiated
laryngeal and hypopharyngeal carcinomas. Otolaryngol Head
Neck Surg. 2000;122(6):892–898.
(6). Saydam L, Kalcioglu T, Kizilay A. Early oral feeding following
total laryngectomy. Am J Otolaryngol. 2002;23(5):277–281.
(7). Parikh SR, Irish JC, Curran AJ, Gullane PJ, Brown DH, Rotstein
LE. Pharyngocutaneous ﬁstulae in laryngectomy patients: the
Toronto hospital experience. J Otolaryngol. 1998;27(3):136.
(8). Bresson K, Rasmussen H, Rasmussen PA. Pharyngo-cutaneous
ﬁstulae in totally laryngectomized patients. J Laryngol Otol.
1974;88(09):835–842.
(9). Ma¨kitie AA, Irish J, Gullane PJ. Pharyngocutaneous ﬁstula. Curr
Opin Otolaryngol Head Neck Surg. 2003;11(2):78.
(10). Galli J, De Corso E, Volante M, Almadori G, Paludetti G.
Postlaryngectomy pharyngocutaneous ﬁstula: incidence, predis-
posing factors, and therapy. Otolaryngol Head Neck Surg.
2005;133(5):689.
(11). Pinar E, Oncel S, Calli C, Guclu E, Tatar B. Pharyngocutaneous
ﬁstula after total laryngectomy: emphasis on lymph node
metastases as a new predisposing factor. J Otolaryngol Head
Neck Surg. Jun 2008;37(3):312–318.
(12). Seikaly H, Park P. Gastroesophageal reﬂux prophylaxis
decreases the incidence of pharyngocutaneous ﬁstula after total
laryngectomy. Laryngoscope. 1995;105(11):1220–1222.
(13). Udaipurwala I, Iqbal K, Jalisi M. Pharyngocutaneous ﬁstula
following laryngectomy. JPMA. 1995;45(5):130.
(14). Ganly I, Patel S, Matsuo J, et al. Postoperative complications of
salvage total laryngectomy. Cancer. 2005;103(10):2073–2081.
(15). Cavalot AL, Gervasio CF, Nazionale G, et al. Pharyngocuta-
neous ﬁstula as a complication of total laryngectomy: review of
the literature and analysis of case records. Otolaryngol Head
Neck Surg. 2000;123(5):587.
(16). Guclu E, Pinar E, Oncel S, Calli C. Pharyngocutaneous ﬁstula
after total laryngectomy: incidence and analysis of risk factors.
Kulak Burun Bogaz Ihtis Derg. 2007;17(5):260–264.
(17). Kasapo lu F, Eri en L, Co kun H, et al. The management of
pharyngocutaneous ﬁstulas after total laryngectomy and the
factors affecting their incidence. Kulak burun Bogaz Ihtis Derg.
2003;11(1):5.
(18). Chee N, Siow JK. Pharyngocutaneous ﬁstula after laryngec-
tomy–incidence, predisposing factors and outcome. Singapore
Med J. Mar 1999;40(3):130–132.
(19). Dedivitis RA, Ribeiro KC, Castro MA, Nascimento PC.
Pharyngocutaneous ﬁstula following total laryngectomy. Acta
Otorhinolaryngol Ital. Feb 2007;27(1):2–5.
(20). Grau C, Johansen LV, Hansen HS, et al. Salvage laryngectomy
and pharyngocutaneous ﬁstulae after primary radiotherapy for
head and neck cancer: a national survey from DAHANCA.
Head Neck. Sep 2003;25(9):711–716.
(21). Saki N, Nikakhlagh S, Kazemi M. Pharyngocutaneous ﬁstula
after laryngectomy: incidence, predisposing factors, and out-
come. Arch Iran Med. May 2008;11(3):314–317.
(22). Teknos TN, Myers LL. Surgical reconstruction after chemo-
therapy or radiation. Problems and solutions. Hematol Oncol
Clin North Am. Aug 1999;13(4):679–687.
(23). McCombe AW, Jones AS. Radiotherapy and complications of
laryngectomy. J Laryngol Otol. Feb 1993;107(2):130–132.
(24). Chang DW, Hussussian C, Lewin JS, Youssef AA, Robb GL,
Reece GP. Analysis of pharyngocutaneous ﬁstula following free
jejunal transfer for total laryngopharyngectomy. Plast Reconstr
Surg. 2002;109(5):1522–1527.
(25). Boscolo-Rizzo P, De Cillis G, Marchiori C, Carpene` S, Da
Mosto MC. Multivariate analysis of risk factors for pharyngo-
cutaneous ﬁstula after total laryngectomy. Eur Arch Otorhino-
laryngol. 2008;265(8):929–936.
(26). Jovanovi M, Perovi J, Grubor A. The impact of diabetes mellitus
on postoperative morbidity in laryngeal surgery. Acta Chir
Iugosl. 2006;53(1):51–55.
106 A.A. Arain et al.
